These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19229700)

  • 1. Hypermethylation of genes for diagnosis and risk stratification of prostate cancer.
    Vanaja DK; Ehrich M; Van den Boom D; Cheville JC; Karnes RJ; Tindall DJ; Cantor CR; Young CY
    Cancer Invest; 2009 Jun; 27(5):549-60. PubMed ID: 19229700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
    Yegnasubramanian S; Kowalski J; Gonzalgo ML; Zahurak M; Piantadosi S; Walsh PC; Bova GS; De Marzo AM; Isaacs WB; Nelson WG
    Cancer Res; 2004 Mar; 64(6):1975-86. PubMed ID: 15026333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.
    Mitsui Y; Shiina H; Hiraki M; Arichi N; Hiraoka T; Sumura M; Honda S; Yasumoto H; Igawa M
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):487-96. PubMed ID: 22246902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
    Ellinger J; Bastian PJ; Jurgan T; Biermann K; Kahl P; Heukamp LC; Wernert N; Müller SC; von Ruecker A
    Urology; 2008 Jan; 71(1):161-7. PubMed ID: 18242387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [GSTP1 CpG island hypermethylation as a molecular marker of prostate cancer].
    Bastian PJ; Nakayama M; De Marzo AM; Nelson WG
    Urologe A; 2004 May; 43(5):573-9. PubMed ID: 15029477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma.
    Chuang CK; Chu DC; Tzou RD; Liou SI; Chia JH; Sun CF
    Cancer Detect Prev; 2007; 31(1):59-63. PubMed ID: 17291695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma.
    Jerónimo C; Henrique R; Campos PF; Oliveira J; Caballero OL; Lopes C; Sidransky D
    J Clin Pathol; 2003 Jan; 56(1):52-5. PubMed ID: 12499435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Restriction landmark genomic scanning for screening aberrant CpG methylations in prostate cancer].
    Li D; Xu Z; Liu J; Pu X; Luo Y; Zheng X
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):103-8. PubMed ID: 26806748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M; Gonzalgo ML; Yegnasubramanian S; Lin X; De Marzo AM; Nelson WG
    J Cell Biochem; 2004 Feb; 91(3):540-52. PubMed ID: 14755684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global methylation profiling for risk prediction of prostate cancer.
    Mahapatra S; Klee EW; Young CY; Sun Z; Jimenez RE; Klee GG; Tindall DJ; Donkena KV
    Clin Cancer Res; 2012 May; 18(10):2882-95. PubMed ID: 22589488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
    Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.
    Zhang W; Shu P; Wang S; Song J; Liu K; Wang C; Ran L
    Gene; 2018 Oct; 675():136-143. PubMed ID: 29966681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
    Basu S; Majumder S; Bhowal A; Ghosh A; Naskar S; Nandy S; Mukherjee S; Sinha RK; Basu K; Karmakar D; Banerjee S; Sengupta S
    PLoS One; 2015; 10(5):e0125560. PubMed ID: 25938433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
    Goessl C; Krause H; Müller M; Heicappell R; Schrader M; Sachsinger J; Miller K
    Cancer Res; 2000 Nov; 60(21):5941-5. PubMed ID: 11085508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
    Babalyan KA; Sultanov R; Generozov EV; Zakharzhevskaya NB; Sharova EI; Peshkov MN; Vasilev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Babikova EA; Larin AK; Govorun VM
    Vopr Onkol; 2016; 62(1):122-32. PubMed ID: 30444590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
    Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
    Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Pookot D; Li LC; Tabatabai ZL; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Int J Cancer; 2005 Aug; 116(2):174-81. PubMed ID: 15800905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
    Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
    Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH; Lee S; Lee HJ; Hwang KS
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.